Who: University of Texas at Arlington.
What: Copper-cysteamine (Cu-Cy) nanoparticles combined with X-ray exposure, that significantly slow tumor growth in lab studies. See “A New X-Ray Activated Nanoparticle Photosensitizer for Cancer Treatment”
Where: Photodynamic cancer therapy, a technique in which a photosensitizer is introduced into tumor tissue. When exposed to light, the photosensizer produces singlet oxygen that kills the cancer cells.
When: The University has filed a provisional patent application on the new complex. Commercialization would be a number of years away for such a technology in the biomedical industry.
